Overall, the close relationship between metabolic and respiratory impairment suggests that lung innate immunity, as inferred from genetic or phenotypic SP-D variation, could reside at the intersect of inflammation, obesity, and insulin resistance. This evidence concerns the gene SFTPD and obesity disorder.